Jon joined Oxford Science Enterprises in July 2020 and advises the Life Sciences team, bringing over 20 years of investment experience from across the Life Science industry.
Jon is also a Partner at Rosetta Capital, a Venture Capital firm focused on the life science and medical technology sectors, which he co-founded in 2009.
He started his investment career at Rothschild Asset Management before co-founding BioScience Managers in 2001. Jon also served as a Partner at Seroba Life Sciences and has held a number of portfolio Board director roles, including Aprea Therapeutics, Covagen AG, Opsona Therapeutics, Catalyst Biosciences, Glycomimetics, NovImmune, Carrick Therapeutics and Mission Therapeutics.
Jon has a PhD in Cancer Research from the University of Cambridge and a BA in Biology from the University of Oxford.
